Nanjing Pharmaceutical Group Company LimitedSSE: 600713

Announcement on Interest Payment for Corporate Convertible Bonds in 2025

· Issued by Nanjing Pharmaceutical Group Company Limited via Shanghai Stock Exchange

Filed with SSE · · 5 pages · Chinese

Summary by 6ix AI

The bonds will begin interest payments on a specified date, covering the period from the previous year. The announcement includes important dates such as the record date and payment date for bondholders. The interest amount per bond is specified, along with tax implications for investors.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Interest Payment for Corporate Convertible Bonds in 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Nanjing Pharmaceutical Group Company Limited on 6ix

Earlier from Nanjing Pharmaceutical

Later from Nanjing Pharmaceutical

All Nanjing Pharmaceutical news releases